Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Nickel, Nils
NCT05983250: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF	Recruiting	3	152	Canada, US	TNX-103, Placebo	Tenax Therapeutics, Inc., Medpace, Inc., Northwestern University	Pulmonary Hypertension	03/27	07/27